GoodRx Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
GoodRx Holdings, Inc. (GDRX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $17.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2026-02-26
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2025 was $17.30M, a 33.97% decline from fiscal 2024.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2024 was $26.20M, a 9.03% decline from fiscal 2023.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2023 was $28.80M, a 97.26% increase from fiscal 2022.
- GoodRx Holdings, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2022 was $14.60M, a 4.58% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2025-12-31 | $17.30M 10-K · filed 2026-02-26 |
| 2024-12-31 | $26.20M 10-K · filed 2026-02-26 |
| 2023-12-31 | $28.80M 10-K · filed 2026-02-26 |
| 2022-12-31 | $14.60M 10-K · filed 2025-02-27 |
| 2021-12-31 | $15.30M 10-K · filed 2024-02-29 |
| 2020-12-31 | $10.20M 10-K · filed 2023-03-01 |
| 2019-12-31 | $2.50M 10-K · filed 2022-03-01 |
| 2018-12-31 | $1.60M 10-K · filed 2021-03-12 |